Share Email Print
cover

Proceedings Paper

Mild Hyperthermia Synergistically Enhances Killing Of Malignant Cells By The Cationic Photosensitizer EDKC: Implications For A "Selective Photo-Hyperthermic Therapy"
Author(s): A. R. Oseroff; D. Ohuoha; G. Ara
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Cationic dyes such as EDKC, which preferentially accumulate in malignant cell mitochondria, permit selective photodamage and dark toxicity to these organelles. The resultant inhibition of oxidative phosphorylation and decrease in intracellular ATP should strongly potentiated thermal injury, even at temperatures which are relatively innocuous by themselves. In human squamous carcinoma (FaDu), murine melanoma (B-16) or non-malignant monkey kidney (CV-1) cells, we examined the effect of combining treatment with EDKC ± light together with mild, 42°C hyperthermia. Heat alone for up to 60 min had no effect on any of the cell lines, and EDKC + light + heat was not toxic to the non-malignant CV-1 cells. Hyperthermia synergistically enhanced photodamage in malignant cells, with survival decreasing more than 200-fold after 20 min of heat to B-16 cells or 60 min to FaDu cells. The heating also increased dark toxicity of the dye, decreasing survival of FaDu cells by more than 10-fold after treatment with 10-7 M EDKC and 60 minutes at 42°C. The sequence of application of light and heat was important, with much greater synergy for heat after irradiation.

Paper Details

Date Published: 19 February 1988
PDF: 4 pages
Proc. SPIE 0847, New Directions in Photodynamic Therapy, (19 February 1988); doi: 10.1117/12.942684
Show Author Affiliations
A. R. Oseroff, Tufts-New England Medical Center (United States)
D. Ohuoha, Tufts-New England Medical Center (United States)
G. Ara, Tufts-New England Medical Center (United States)


Published in SPIE Proceedings Vol. 0847:
New Directions in Photodynamic Therapy
Douglas C. Neckers, Editor(s)

© SPIE. Terms of Use
Back to Top